Protective effect of the IUD on the incidence of cervical câncer: a review of clinical and epidemiological evidence
Protective effect of the IUD on the incidence of cervical câncer: a review of clinical and epidemiological evidence
DOI:
https://doi.org/10.51473/rcmos.v1i1.2026.2004Keywords:
IUD; cervical cancer; HPV; Prevention.Abstract
Cervical cancer remains a significant global public health challenge, particularly in regions with limited access to screening and HPV vaccination. In this context, scientific interest has grown regarding whether the intrauterine device (IUD), beyond its role as an effective contraceptive, may also offer additional protective effects against cervical carcinogenesis. This study aimed to critically analyze clinical and epidemiological evidence on the relationship between IUD use and reduced incidence of cervical cancer. A qualitative bibliographic investigation was conducted through a narrative review of studies published between 2000 and 2025, retrieved from indexed databases such as PubMed, SciELO, LILACS, and Web of Science. The results suggest that IUD users, especially copper IUD users, show a lower risk of developing high-grade cervical lesions and invasive cervical cancer. Proposed mechanisms include local inflammatory responses, enhanced immune surveillance, modulation of the cervical microbiome, and increased adherence to cytological screening. However, the literature remains heterogeneous, with variations related to the type of IUD, user characteristics, and behavioral confounders. In conclusion, the IUD may represent an additional protective factor against cervical cancer but should not replace essential preventive measures such as vaccination and regular screening. Future research should explore biological mechanisms more deeply and rigorously compare the effects of different types of IUDs.
Downloads
References
CASTELLSAGUÉ, X.; DÍAZ, M.; VACCARELLA, S. et al. Intrauterine device use and cervical cancer risk: a pooled analysis of 26 epidemiological studies. The Lancet Oncology, v. 12, n. 11, p. 1023–1031, 2011.
CORREIA, L. et al. Contraceção em mulheres com cancro ginecológico: recomendações atuais. Acta Médica Portuguesa, v. 38, n. 1, p. 54–61, 2025.
CORTÉSSIS, V. K. et al. Intrauterine device use and cervical cancer risk: a systematic review and meta-analysis. Obstetrics & Gynecology, v. 130, n. 6, p. 1226–1236, 2017.
DE CURSO, T. C. et al. Alterações citopatológicas cervicais em usuárias de métodos contraceptivos: análise comparativa entre DIU e contraceptivos orais. Revista UNESP de Ciências da Saúde, v. 18, n. 2, p. 145–159, 2023.
GRIS, T. B. et al. Intrauterine devices: what has changed? Saúde & Contracepção, v. 4, n. 1, p. 1–12, 2025.
LESSA, A. et al. Use of intrauterine contraception and risk of gynaecological cancers: umbrella review of systematic reviews and meta-analyses. Journal of Gynecologic Oncology, v. 34, n. 2, e70, 2023.
MURITHI, M. K.; OGETO, T. K.; WALEKHWA, M. N.; NJUNGE, R. K.; LAGAT, M.; MALAGO, Z. L. Oral contraceptives and intrauterine devices as risk factors for breast and cervical cancers: a systematic review. Scientific Journal of Medicine, v. 4, n. 1, p. 33–47, 2020.
SPOTNITZ, M. E. et al. Relative risk of cervical neoplasms among copper and levonorgestrel-releasing intrauterine system users. Obstetrics & Gynecology, v. 135, n. 4, p. 863–872, 2020.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Natália Maria Vitório Pereira, Rebeka Caroline Moreira (Autor)

This work is licensed under a Creative Commons Attribution 4.0 International License.


